Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
11.2M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
26.8M
-
Shares change
-
-701K
-
Total reported value, excl. options
-
$119M
-
Value change
-
-$4.07M
-
Number of buys
-
18
-
Number of sells
-
-35
-
Price
-
$4.43
Significant Holders of ImageneBio, Inc. - Common Stock, $0.001 par value (IKNA) as of Q2 2022
59 filings reported holding IKNA - ImageneBio, Inc. - Common Stock, $0.001 par value as of Q2 2022.
ImageneBio, Inc. - Common Stock, $0.001 par value (IKNA) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.8M shares
.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (5.02M shares), FMR LLC (4.4M shares), ORBIMED ADVISORS LLC (2.93M shares), BVF INC/IL (2.5M shares), Omega Fund Management, LLC (2.25M shares), CITADEL ADVISORS LLC (2.13M shares), Artal Group S.A. (1.55M shares), CHI Advisors LLC (1.09M shares), Verition Fund Management LLC (1.02M shares), and Point72 Asset Management, L.P. (689K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.